A clinical study to determine the threshold of bronchodilator response for diagnosing asthma in Chinese children

Xiao-Hui Kang1, Wan Wang2, Ling Cao3

  • 1Children's Hospital Affiliated to the Capital Institute of Pediatrics, No.2 Ya bao Road, Chaoyang District, Beijing, China.

Insights

A bronchodilator response (BDR) threshold of 7.5% is valuable for diagnosing childhood asthma. This simple spirometry test offers a better balance of sensitivity and specificity than a 12% threshold.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Diagnostic Testing

Background:

  • Childhood asthma diagnosis lacks objective, feasible, and inexpensive tests.
  • Current diagnostic methods may not meet clinical needs for accuracy and accessibility.
  • There is a need for an improved diagnostic approach for pediatric asthma.

Purpose of the Study:

  • To evaluate the diagnostic value of bronchodilator response (BDR) in childhood asthma.
  • To determine an optimal BDR threshold for diagnosing asthma in children.
  • To compare the effectiveness of different BDR thresholds in asthma diagnosis.

Main Methods:

  • Spirometry tests were conducted before and after bronchodilator administration in 286 asthmatic and 301 non-asthmatic children.
  • Bronchodilator response (BDR) was calculated as the change in forced expiratory volume in the first second (FEV1) post-bronchodilator.
  • Receiver-operating characteristic (ROC) curve analysis was used to identify the optimal BDR threshold.

Main Results:

  • Asthmatic children showed significantly lower pre-bronchodilator FEV1 compared to non-asthmatic children (P≤0.01).
  • Mean BDR was 9.45±9.15% in asthmatic children versus 3.30±3.85% in non-asthmatic children.
  • A BDR threshold of ≥7.5% yielded 50.7% sensitivity and 87.7% specificity, while ≥12% yielded 28.7% sensitivity and 96.3% specificity.

Conclusions:

  • A bronchodilator response (BDR) threshold of ≥7.5% demonstrates greater diagnostic utility in childhood asthma compared to a ≥12% threshold.
  • The BDR test, particularly at a 7.5% threshold, offers a clinically feasible and potentially valuable tool for asthma diagnosis in children.
  • Further research may refine the role of BDR in pediatric asthma management and diagnosis.
Abstract

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
746
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.1K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K